Patrick N. Cunningham, MD

  • Associate Professor of Medicine
    Committee on Clinical Pharmacology and Pharmacogenomics
  • Clinical Interests: Glomerulonephritis, Hemolytic Uremic Syndrome, Kidney Biopsy, Nephrotic Syndrome
  • Websites: Research Network Profile
  • Contact: cunningp@uchicago.edu

Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study. Transplantation. 2024 08 01; 108(8):1782-1792.
PMID: 39042770

Acute Kidney Injury in Coronavirus Disease and Association with Thrombosis.
Acute Kidney Injury in Coronavirus Disease and Association with Thrombosis. Am J Nephrol. 2023; 54(3-4):156-164.
PMID: 37019091

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection.
Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
PMID: 34272370

Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA.
Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA. Am J Kidney Dis. 2020 04; 75(4):513-516.
PMID: 31866228

The Epidemiologic Burden of Tacrolimus Variability among Kidney Transplant Recipients in the United States.
The Epidemiologic Burden of Tacrolimus Variability among Kidney Transplant Recipients in the United States. Am J Nephrol. 2019; 50(5):370-374.
PMID: 31553982

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. PLoS One. 2019; 14(9):e0221957.
PMID: 31532792

The future of pharmacogenetics in the treatment of hypertension.
The future of pharmacogenetics in the treatment of hypertension. Pharmacogenomics. 2019 02; 20(3):129-132.
PMID: 30808251

Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.
Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection. Hum Pathol. 2018 06; 76:47-51.
PMID: 29501487

Patient-Reported Barriers to the Prekidney Transplant Evaluation in an At-Risk Population in the United States.
Patient-Reported Barriers to the Prekidney Transplant Evaluation in an At-Risk Population in the United States. Prog Transplant. 2017 06; 27(2):131-138.
PMID: 28617167

Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach. Int J Mol Sci. 2017 Mar 18; 18(3).
PMID: 28335481

View All Publications